The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries: Early Outcome of the Benestent-II Pilot Study
Open accessAbstract
Background The purpose of the Benestent-II Pilot Study was to evaluate the safety of delaying and eliminating anticoagulant therapy in patients receiving a heparin-coated stent in conjunction with antiplatelet drugs. Methods and Results The study consisted of three initial phases (I, II, III) during which resumption of heparin therapy after sheath removal was progressively deferred by 6, 12, and 36 hours. In phase IV, coumadin and heparin were replaced by 250 mg ticlopidine and 100 mg aspirin. Of the 207 patients with stable angina pectoris and a de novo lesion in whom heparin-coated stent implantation was attempted, implantation was successful in 202 patients (98%). Stent thrombosis did not occur during all four phases, and the overall clinical success rate at discharge was 99%. Bleeding complications requiring blood transfusion or surgery fell from 7.9% in phase I to 5.9%, 4%, and 0% in the three following phases. Hospital stay was 7.4, 6.1, 7.2, and 3.1 days for the consecutive phases. The restenosis rate for the combined four phases was 13% (15% in phase I, 20% in phase II, 11% in phase III, and 6% in phase IV). The overall rate of reintervention for the four phases was 8.9%. At 6 months, 84%, 75%, 94%, and 92% of the patients of phases I to IV, respectively, were event free. For the four phases, the event-free rate was 86%, which compares favorably with the rate observed in the Benestent-I study (80%; relative risk, 0.68 [0.45 to 1.04]). Conclusions The implantation of stents coated with polyamine and end-point–attached heparin in stable patients with one significant de novo coronary lesion is well tolerated, is associated with no (sub)acute stent thrombosis, and results in a favorable event-free survival after 6 months.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serruys, P. W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., Emanuelsson, H., Marco, J., Legrand, V., Materne, P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310801 · Cited by 4,556
Self-citationIntracoronary Stenting Without Anticoagulation Accomplished With Intravascular Ultrasound Guidance
Colombo, A., Hall, P., Nakamura, S., Almagor, Y., Maiello, L., Martini, G., Gaglione, A., Goldberg, S. L., & Tobis, J. M. (1995) · Circulation · doi:10.1161/01.cir.91.6.1676 · Cited by 1,428
Self-citationThe Electrocardiogram in Population Studies: A Classification System
BLACKBURN, H., KEYS, A., SIMONSON, E., RAUTAHARJU, P., & PUNSAR, S. (1960) · Circulation · doi:10.1161/01.cir.21.6.1160 · Cited by 1,109
Angiographie morphology and the pathogenesis of unstable angina pectoris
Ambrose, J. A., Winters, S. L., Stern, A., Eng, A., Teichholz, L. E., Gorlin, R., & Fuster, V. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80384-3 · Cited by 801
Estimation of a Common Effect Parameter from Sparse Follow-Up Data
Greenland, S., & Robins, J. M. (1985) · Biometrics · doi:10.2307/2530643 · Cited by 794
Effect of Heparin and Heparin Fractions on Platelet Aggregation
Salzman, E. W., Rosenberg, R. D., Smith, M. H., Lindon, J. N., & Favreau, L. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109661 · Cited by 591
Heparin : chemical and biological properties, clinical applications
Lane, D. A., & Lindahl, U. (1989) · Edward Arnold eBooks · Cited by 533
Further characterization of the antithrombin-binding sequence in heparin
Thunberg, L., Bäckström, G., & Lindahl, U. (1982) · Carbohydrate Research · doi:10.1016/s0008-6215(00)81050-2 · Cited by 455
Larm, O., Larsson, R., & Olsson, P. (1983) · Biomaterials, Medical Devices, and Artificial Organs · doi:10.3109/10731198309118804 · Cited by 437
Structure of the antithrombin-binding site in heparin.
Lindahl, U., Bäckström, G., Höök, M., Thunberg, L., Fransson, L. A., & Linker, A. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3198 · Cited by 368
Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells
Marcum, J. A., & Rosenberg, R. D. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)90615-1 · Cited by 203
Concise encyclopedia of medical and dental materials
Watts, D. C. (1993) · Journal of Dentistry · doi:10.1016/0300-5712(93)90117-9 · Cited by 189
Hårdhammar, P. A., van Beusekom, H. M. M., Emanuelsson, H. U., Hofma, S. H., Albertsson, P. A., Verdouw, P. D., Boersma, E., Serruys, P. W., & van der Giessen, W. J. (1996) · Circulation · doi:10.1161/01.cir.93.3.423 · Cited by 187
Self-citationCOVALENT BINDING OF BIOMOLECULES TO RADIATION-GRAFTED HYDROGELS ON INERT POLYMER SURFACES
Hoffman, A. S., Schmer, G., Harris, C., & Kraft, W. G. (1972) · ASAIO Journal · doi:10.1097/00002480-197201000-00003 · Cited by 166
Chiellini, E., & Giusti, P. (1983) · Springer eBooks · doi:10.1007/978-1-4615-7643-3 · Cited by 104
Heparinized polyurethanes: In vitro and in vivo studies
Heyman, P. W., Cho, C. S., McRea, J. C., Olsen, D. B., & Kim, S. (1985) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820190407 · Cited by 93
A canine ex vivo series shunt for evaluating thrombus deposition on polymer surfaces
Lelah, M. D., Lambrecht, L. K., & Cooper, S. L. (1984) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820180503 · Cited by 86
Nonthrombogenic materials via a simple coating process.
Grode, G. A., Anderson, S. J., Grotta, H. M., & Falb, R. D. (1969) · PubMed · Cited by 85
Principles of heparin-coating techniques
Hsu, L.-C. (1991) · Perfusion · doi:10.1177/026765919100600310 · Cited by 52
Ticlopidine, Platelets and Vascular Disease
(1993) · Springer eBooks · doi:10.1007/978-1-4613-8306-2 · Cited by 41
Benestent II: Back to the Future
Emanuelsson, H., van der Giessen, W. J., Serruys, P. W. J. C., & ON BEHALF OF THE BENESTENT GROUP (1994) · Journal of Interventional Cardiology · doi:10.1111/j.1540-8183.1994.tb00500.x · Cited by 10
Self-citation
Cited by
WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
Schömig, A., Neumann, F.-J., Kastrati, A., Schühlen, H., Blasini, R., Hadamitzky, M., Walter, H., Zitzmann-Roth, E.-M., Richardt, G., Alt, E., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604253341702 · Cited by 2,028
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
Leon, M. B., Baim, D. S., Popma, J. J., Gordon, P. C., Cutlip, D. E., Ho, K. K. L., Giambartolomei, A., Diver, D. J., Lasorda, D. M., Williams, D. O., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812033392303 · Cited by 1,815
Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction
Grines, C. L., Cox, D. A., Stone, G. W., Garcia, E., Mattos, L. A., Giambartolomei, A., Brodie, B. R., Madonna, O., Eijgelshoven, M., Lansky, A. J., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412601 · Cited by 946
Self-citation
Metadata
- Authors
- Serruys, P. W., Emanuelsson, H., van der Giessen, W., Lunn, A. C., Kiemeney, F., Macaya, C., Rutsch, W., Heyndrickx, G., Suryapranata, H., Legrand, V., Goy, J. J., Materne, P., Bonnier, H., Morice, M.-C., Fajadet, J., Belardi, J., Colombo, A., Garcia, E., Ruygrok, P., de Jaegere, P., & Morel, M.-A.
- Venue
- Circulation
- Published
- 1996-02
- Volume
- 93
- Issue
- 3
- Pages
- 412-422
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2140150910
- Cited by
- 408
- References
- 21
- FWCI
- 88.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.